Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-08T05:46:41.853Z Has data issue: false hasContentIssue false

Evaluating North Carolina’s policy for healthcare personnel living with HIV and hepatitis B who perform invasive procedures after 25 years of implementation

Published online by Cambridge University Press:  27 January 2020

Cedar L. Mitchell*
Affiliation:
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina
James W. Lewis
Affiliation:
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina North Carolina Division of Public Health, Raleigh, North Carolina
Jean-Marie Maillard
Affiliation:
North Carolina Division of Public Health, Raleigh, North Carolina
Zack S. Moore
Affiliation:
North Carolina Division of Public Health, Raleigh, North Carolina
David J. Weber
Affiliation:
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina
*
Author for correspondence: Cedar L. Mitchell, E-mail: cedarmit@live.unc.edu
Rights & Permissions [Opens in a new window]

Abstract

Healthcare personnel who perform invasive procedures and are living with HIV or hepatitis B have been required to self-notify the NC state health department since 1992. State coordinated review of HCP utilizes a panel of experts to evaluate transmission risk and recommend infection prevention measures. We describe how this practice balances HCP privacy and patient safety and health.

Information

Type
Concise Communication
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.
Figure 0

Table 1. North Carolina Healthcare Personnel Performing Invasive Procedures Who Self-Reported Living With Hepatitis B or HIV to the North Carolina Division of Public Health (NC DPH) From January 1992 Through August 2018 and Summary of Recommendations for Prevention of Healthcare Provider to Patient Transmission

Figure 1

Table 2. Reasons for Not Convening an Expert Panel to Evaluate Risk of HIV or Hepatitis B Transmission for the 19 HCP Without a Panel

Supplementary material: PDF

Mitchell et al. supplementary material

Appendix A

Download Mitchell et al. supplementary material(PDF)
PDF 193.6 KB